Blocking A Neuropeptide Receptor Decreases Nicotine Addiction
Nov 25th 2008Drug InformationAlcohol / Addiction / Illegal Drugs
The study was published in an online Early Edition issue of the Proceedings of the National Academy of Sciences, the week of November 24. Scripps Florida is a division of The Scripps Research Institute. The neuropeptide, hypocretin-1 (Orexin A), may initiate a key signaling cascade, a series of closely linked biochemical reactions, which maintains tobacco addiction in human smokers and could be a potential target for developing new smoking cessation treatments.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
